Consequently,
Cancerigen risk: prizes ludiomil antidepressant:
Tuesday. However, July 29, the National Medicines Safety Agency announced that the antidepressant Ludiomil will be withdrawn from the market by the end of 2026. Furthermore, Traces of nitrosamine, potentially dangerous impurities, were detected at too high levels, exceeding the thresholds authorized by the European Union.
Removing the Ludiomil from the market – Cancerigen risk: prizes ludiomil antidepressant
The National Medicines Safety Agency (ANSM) announced on July 29 that the antidepressant Ludiomil will be withdrawn from the market by the end of 2026. This decision was detected in the detection of abnormal levels of nitrosamines. substances considered as possible carcinogens, report national media as Libération et TF1Info. Consequently, the ANSM recommends that patients replace this medication with alternatives such as amitriptyline or mirtazapine. THE Ludiomil is currently prescribed for around 5,000 people in France, mainly seniors over 60 years of age.
> Read also: Reminder cancerigen risk: prizes ludiomil antidepressant in France of 32. 000 lisinopril boxes, a hypertension medication
Measures and precautions to be taken
Although the production of Ludiomil has already been suspended in March 2025, confirmation of the presence of nitrosamines rushed to its withdrawal. The ANSM reminds patients not to interrupt their treatment without the advice of a doctor. because a brutal stop could have more risks than exposure to impurities. New bots of the drug should be available at the end of 2026, once the problems are resolved.
> AllNews in France on Linfo.re
(function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = “//connect.facebook.net/fr_FR/sdk.js#xfbml=1&version=v2.8&appId=369741996706536”; fjs.parentNode.insertBefore(js, fjs); }(document, ‘script’, ‘facebook-jssdk’));(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = “//connect.facebook.net/fr_FR/sdk.js#xfbml=1&version=v2.0”; fjs.parentNode.insertBefore(js. fjs); }(document, ‘script’, ‘facebook-jssdk’));
cancerigen risk: prizes ludiomil antidepressant — cancerigen risk: prizes ludiomil antidepressant Cancerigen risk: prizes ludiomil antidepressant: Tuesday, July 29, the National Medicines Safety Agency announced that the antidepressant Ludiomil will be withdrawn from the market by the end of 2026. Traces of nitrosamine, potentially dangerous impurities, were detected at too h.
Further reading: Fibromyalgia: a real disease to be treated first by physical activity, according to the High Authority for Health – Living near the ocean breeze can prolong life expectancy – still a path to go – The US Senate approves $ 9 billion in budget cuts requested by Trump – Lung cancer: radiotherapy can counter immunotherapy resistance | The doctor’s daily life | Specialties.